Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 312.50 | 169.63 | 226.00 | 278.75 | 0.8108 | 0.4924 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 146.00 | 278.75 | 0.5238 | -0.1888 | |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 312.50 | 169.63 | 229.00 | 278.75 | 0.8215 | 0.5202 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 312.50 | 169.63 | 222.00 | 278.75 | 0.7964 | 0.4557 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 312.50 | 169.63 | 310.00 | 278.75 | 1.1121 | 1.3197 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 312.50 | 169.63 | 158.00 | 278.75 | 0.5668 | -0.0943 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 312.50 | 169.63 | 197.00 | 278.75 | 0.7067 | 0.2322 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 312.50 | 169.63 | 133.00 | 278.75 | 0.4771 | -0.2878 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 312.50 | 169.63 | 201.00 | 278.75 | 0.7211 | 0.2672 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 312.50 | 169.63 | 165.00 | 278.75 | 0.5919 | -0.0378 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 169.63 | 302.00 | 278.75 | 1.0834 | 1.2366 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 312.50 | 169.63 | 187.00 | 278.75 | 0.6709 | 0.1458 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 312.50 | 169.63 | 182.00 | 278.75 | 0.6529 | 0.1033 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 312.50 | 169.63 | 137.00 | 278.75 | 0.4915 | -0.2578 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 312.50 | 169.63 | 269.00 | 278.75 | 0.9650 | 0.9031 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 312.50 | 169.63 | 194.00 | 278.75 | 0.6960 | 0.2061 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 312.50 | 169.63 | 160.00 | 278.75 | 0.5740 | -0.0783 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 257.00 | 278.75 | 0.9220 | 0.7857 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 2.00 | 278.75 | 0.0072 | -0.9980 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 2.00 | 650.00 | 0.0031 | -0.9973 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 595.00 | 650.00 | 0.9154 | 0.8076 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 625.00 | 354.63 | 844.00 | 650.00 | 1.2985 | 1.6964 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 778.00 | 650.00 | 1.1969 | 1.4566 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 860.00 | 650.00 | 1.3231 | 1.7550 | |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 625.00 | 354.63 | 430.00 | 650.00 | 0.6615 | 0.2467 |